Spin out from Mount Sinai, New York, where with a $10m NIH grant they developed the ability to carry out mass animal trials but with genetically engineered fruit flies instead of mice (cheaper, faster, more mutations possible). They then screen 2k+ drugs to discover combinations that are less toxic, cheaper, and better performing than standard of care for each patient.
The unique, proprietary data generated from these screens has been used to develop a scalable AI decision support tool, enabling the company to offer instant drug recommendations for oncologists and their patients
https://vivantx.com/
